BYFFY - NORGESTIC TABLETS (PRESCRIPTION DRUG),NDC 00089-0231-50
- MSDS: BYFFY
- Manufacturer: 3M PHARMACEUTICAL SUB OF MINNESOTA MINING AND MFG
- Product Name: NORGESTIC TABLETS (PRESCRIPTION DRUG),NDC 00089-0231-50
- National Stock Number: 6505-00-952-6762
Product Identification
Product ID:NORGESTIC TABLETS (PRESCRIPTION DRUG),NDC 00089-0231-50
MSDS Date:02/17/1995
FSC:6505
NIIN:00-952-6762
MSDS Number: BYFFY
Responsible Party
NORTHRIDGE, CA 91328-0001
US
Emergency Phone: 818-709-3076/612-733-1110
Info Phone: 818-709-3076/612-733-1110
Cage: 04515
Contractor
Telephone: 818-709-3076
Cage: 04515
Ingredients
ACETYLSALICYLIC ACID (ASPIRIN)
CAS: 50-78-2
RTECS: VO0700000
Fraction By Weight: 57%
OSHA PEL 5 MG/M3
ACGIH TLV: 5 MG/M3; 9495
ORPHENADRINE CITRATE
CAS: 4724-58-7
RTECS: KR6125000
Fraction By Weight: 4%
EXCIPIENTS
Fraction By Weight: 35.0%
CAFFEINE
CAS: 58-08-2
RTECS: EV6475000
Fraction By Weight: 4.0%
Hazards
LD50 LC50 Mixture:LD50 (ORAL, ANIMAL) 192-1000 MG/KG
Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:TARGET ORGANS:GASTROINTESTINAL TRACT.
ACUTE- EYE/SKIN/INHALATION:EXPOSURE NOT LIKELY DUE TO THE PHYSICAL
FORM OF THE TABLET. ORAL:MODERATE ORAL TOXICITY. IF SWALLOWED MAY
CAUSE UPSET STOMACH, PAIN, NA USEA. CHRONIC- UNKNOWN.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:NAUSEA, VOMITING
First Aid
First Aid:EYE/SKIN/INHALATION:NOT RELEVANT. ORAL:CALL A PHYSICIAN.
Fire Fighting
Flash Point:NONE
Extinguishing Media:WATER SPRAY, CARBON DIOXIDE, FOAM OR DRY CHEMICAL.
USE WATER SPRAY TO COOL FIRE EXPOSED CONTAINERS.
Fire Fighting Procedures:WEAR PROTECTIVE CLOTHING AND NIOSH-APPROVED
SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:NONE
Accidental Release
Spill Release Procedures:COLLECT SPILLED MATERIAL. PLACE IN AN APPROVED
METAL CONTAINER AND SEAL.
Neutralizing Agent:NOT RELEVANT
Handling
Handling and Storage Precautions:STORE IN COOL PLACE, IN ORIGINAL
CONTAINERS. KEEP OUT OF REACH OF CHILDREN.
Other Precautions:AS A GENERAL RULE, WHEN HANDLING PHARMACEUTICAL OR
LABORATORY PRODUCTS, AVOID ALL FORMS OF CONTACT AND INHALATION OF
DUST, FUMES, MISTS, AND/OR VAPORS ASSOCIATED WITH THE PRODUCT. WASH
THOROUGHLY AFTE R HANDLING AND BEFORE EATING OR DRINKING
Exposure Controls
Respiratory Protection:NONE NORMALLY REQUIRED.
Ventilation:NONE NORMALLY REQUIRED.
Protective Gloves:LATEX RECOMMENDED
Eye Protection:SAFETY GOGGLES RECOMMENDED
Other Protective Equipment:PROVIDE EYE WASH, SAFETY SHOWER AND LAB
COAT.
Work Hygienic Practices:OBSERVE GOOD PERSONAL HYGIENE PRACTICES AND
RECOMMENDED PROCEDURES.
Supplemental Safety and Health
THIS PRODUCT IS APPROVED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION
(FDA) FOR USE AS A PRESCRIPTION DRUG.
Chemical Properties
HCC:T4
NRC/State Lic Num:NOT RELEVANT
Melt/Freeze Pt:M.P/F.P Text:NOT KNOWN
Decomp Temp:Decomp Text:NOT KNOWN
Viscosity:NOT RELEVANT
Evaporation Rate & Reference:NOT RELEVANT
Appearance and Odor:YELLOW/GREEN/WHITE TABLET
Stability
Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:EXCESSIVE HEAT
Hazardous Decomposition Products:CARBON MONOXIDE, CARBON DIOXIDE
Disposal
Waste Disposal Methods:MIX WITH FLAMMABLE MATERIAL AND INCINERATE IN AN
INDUSTRIAL OR COMMERCIAL FACILITY IN ACCORDANCE WITH ALL LOCAL,
STATE AND FEDERAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.